Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration
Post-traumatic osteoarthritis (PTOA) is one of the leading causes of disability in developed countries and accounts for 12% of all osteoarthritis cases in the United States. After trauma, inflammatory cells (macrophages amongst others) are quickly recruited within the inflamed synovium and infiltrat...
| 出版年: | Heliyon |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Elsevier
2023-06-01
|
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2405844023038471 |
| _version_ | 1851924578643738624 |
|---|---|
| author | Chiara Mancino Anna Pasto Enrica De Rosa Luigi Dolcetti Marco Rasponi Patrick McCulloch Francesca Taraballi |
| author_facet | Chiara Mancino Anna Pasto Enrica De Rosa Luigi Dolcetti Marco Rasponi Patrick McCulloch Francesca Taraballi |
| author_sort | Chiara Mancino |
| collection | DOAJ |
| container_title | Heliyon |
| description | Post-traumatic osteoarthritis (PTOA) is one of the leading causes of disability in developed countries and accounts for 12% of all osteoarthritis cases in the United States. After trauma, inflammatory cells (macrophages amongst others) are quickly recruited within the inflamed synovium and infiltrate the joint space, initiating dysregulation of cartilage tissue homeostasis. Current therapeutic strategies are ineffective, and PTOA remains an open clinical challenge. Here, the targeting potential of liposome-based nanoparticles (NPs) is evaluated in a PTOA mouse model, during the acute phase of inflammation, in both sexes. NPs are composed of biomimetic phospholipids or functionalized with macrophage membrane proteins. Intravenous administration of NPs in the acute phase of PTOA and advanced in vivo imaging techniques reveal preferential accumulation of NPs within the injured joint for up to 7 days post injury, in comparison to controls. Finally, imaging mass cytometry uncovers an extraordinary immunomodulatory effect of NPs that are capable of decreasing the amount of immune cells infiltrating the joint and conditioning their phenotype. Thus, biomimetic NPs could be a powerful theranostic tool for PTOA as their accumulation in injury sites allows their identification and they have an intrinsic immunomodulatory effect. |
| format | Article |
| id | doaj-art-5a89910dfdcc4f19aaebba8afb4bc9a6 |
| institution | Directory of Open Access Journals |
| issn | 2405-8440 |
| language | English |
| publishDate | 2023-06-01 |
| publisher | Elsevier |
| record_format | Article |
| spelling | doaj-art-5a89910dfdcc4f19aaebba8afb4bc9a62025-08-19T21:56:58ZengElsevierHeliyon2405-84402023-06-0196e1664010.1016/j.heliyon.2023.e16640Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administrationChiara Mancino0Anna Pasto1Enrica De Rosa2Luigi Dolcetti3Marco Rasponi4Patrick McCulloch5Francesca Taraballi6Center for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, TX, USA; Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, USA; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, ItalyRichard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UKCenter for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, TX, USA; Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, USARichard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UKDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, ItalyOrthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, USACenter for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, TX, USA; Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, USA; Corresponding author.Post-traumatic osteoarthritis (PTOA) is one of the leading causes of disability in developed countries and accounts for 12% of all osteoarthritis cases in the United States. After trauma, inflammatory cells (macrophages amongst others) are quickly recruited within the inflamed synovium and infiltrate the joint space, initiating dysregulation of cartilage tissue homeostasis. Current therapeutic strategies are ineffective, and PTOA remains an open clinical challenge. Here, the targeting potential of liposome-based nanoparticles (NPs) is evaluated in a PTOA mouse model, during the acute phase of inflammation, in both sexes. NPs are composed of biomimetic phospholipids or functionalized with macrophage membrane proteins. Intravenous administration of NPs in the acute phase of PTOA and advanced in vivo imaging techniques reveal preferential accumulation of NPs within the injured joint for up to 7 days post injury, in comparison to controls. Finally, imaging mass cytometry uncovers an extraordinary immunomodulatory effect of NPs that are capable of decreasing the amount of immune cells infiltrating the joint and conditioning their phenotype. Thus, biomimetic NPs could be a powerful theranostic tool for PTOA as their accumulation in injury sites allows their identification and they have an intrinsic immunomodulatory effect.http://www.sciencedirect.com/science/article/pii/S2405844023038471Posttraumatic osteoarthritisBiomimetic nanoparticlesTheranosticsImmunomodulation |
| spellingShingle | Chiara Mancino Anna Pasto Enrica De Rosa Luigi Dolcetti Marco Rasponi Patrick McCulloch Francesca Taraballi Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration Posttraumatic osteoarthritis Biomimetic nanoparticles Theranostics Immunomodulation |
| title | Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration |
| title_full | Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration |
| title_fullStr | Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration |
| title_full_unstemmed | Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration |
| title_short | Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration |
| title_sort | immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration |
| topic | Posttraumatic osteoarthritis Biomimetic nanoparticles Theranostics Immunomodulation |
| url | http://www.sciencedirect.com/science/article/pii/S2405844023038471 |
| work_keys_str_mv | AT chiaramancino immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration AT annapasto immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration AT enricaderosa immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration AT luigidolcetti immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration AT marcorasponi immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration AT patrickmcculloch immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration AT francescataraballi immunomodulatorybiomimeticnanoparticlestargetarticularcartilagetraumaaftersystemicadministration |
